Weltrix Biometrics

Executive Summary

Weltrix Biometrics is a San Francisco-based contract research organization (CRO) specializing in biometrics services for emerging to mid-size biotech sponsors. Founded in 2019, the company offers end-to-end statistical programming, biostatistics, clinical data management, and regulatory support, with a focus on preparing submissions (IND/NDA/BLA/ANDA) and ensuring compliance with CDISC, FDA, EMA, and other global standards. Its senior-led, technically deep approach positions it as a reliable partner for biotech firms seeking expertise in clinical data and statistical services. While still private and with no disclosed funding or valuation, Weltrix targets a niche market of sponsors that require high-quality, regulated biometrics support. The company's growth is tied to the increasing complexity of clinical trials and demand for specialized CRO services, but its limited scale and competition from larger CROs present challenges. Overall, Weltrix Biometrics is well-positioned within its niche, with potential to capture market share by leveraging its technical depth and regulatory focus.

Upcoming Catalysts (preview)

• H2 2026Securing a Major Biotech Collaboration70% success
• Q3 2026Expansion into Oncology Biometrics Services60% success
• Q4 2026Achieving Full CDISC Certification for All Services80% success